Updated:
Alwin Capital
Alwin Capital is a venture capital firm in China focused on early-stage life science investments. It has made 30 investments, including a Series C investment...
Overview
Alwin Capital is a venture capital firm in China focused on early-stage life science investments. It has made 30 investments, including a Series C investment in Pulimeng on July 31, 2025. The firm has one portfolio exit, Edge Medical, which exited on January 08, 2026.
General information
Firm type
Private Equity
Year founded
2015
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Frequently asked questions
What stages does Alwin Capital target?
Available strategy tags list early stage seed, start-up, growth, and expansion investments.
Where is Alwin Capital headquartered?
The firm is based in Beijing, China.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: